Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Haematologica
|
January 2, 2008
Biochemical markers predictive for bone marrow involvement in systemic mastocytosis
Marjolein L Donker, Jasper J van Doormaal, Frederiek F van Doormaal, et al.
Allergy
|
September 25, 2002
The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust mites
I Terreehorst, H J Duivenvoorden, Z Tempels-Pavlica, et al.
Allergy
|
December 15, 2010
Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis
M Niedoszytko, M Bruinenberg, J J van Doormaal, et al.
The Journal of Allergy and Clinical Immunology
|
September 5, 2002
Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study
Albert-Jan Oosting, Marjolein S de Bruin-Weller, Ingrid Terreehorst, et al.
Pediatric Dermatology
|
September 16, 2008
Mastocytosis in children: a protocol for management
Rogier Heide, Auke Beishuizen, Hans De Groot, et al.
Allergy
|
January 7, 2011
Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis
M Niedoszytko, J N G Oude Elberink, M Bruinenberg, et al.
The Journal of Allergy and Clinical Immunology
|
March 19, 2013
Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis
Bjorn van Anrooij, Eveline van der Veer, Jan G R de Monchy, et al.
Clinical Immunology (Orlando, Fla.)
|
December 27, 2011
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
J J Hofstra, I Kleine Budde, E van Twuyver, et al.
Allergy
|
March 23, 2012
Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions
J J van Doormaal, E van der Veer, P C van Voorst Vader, et al.
The European Respiratory Journal
|
February 13, 2010
Application of a prediction model for work-related sensitisation in bakery workers
E Meijer, E Suarthana, J Rooijackers, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Haematologica
|
January 2, 2008
Biochemical markers predictive for bone marrow involvement in systemic mastocytosis
Marjolein L Donker, Jasper J van Doormaal, Frederiek F van Doormaal, et al.
Allergy
|
September 25, 2002
The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust mites
I Terreehorst, H J Duivenvoorden, Z Tempels-Pavlica, et al.
Allergy
|
December 15, 2010
Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis
M Niedoszytko, M Bruinenberg, J J van Doormaal, et al.
The Journal of Allergy and Clinical Immunology
|
September 5, 2002
Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study
Albert-Jan Oosting, Marjolein S de Bruin-Weller, Ingrid Terreehorst, et al.
Pediatric Dermatology
|
September 16, 2008
Mastocytosis in children: a protocol for management
Rogier Heide, Auke Beishuizen, Hans De Groot, et al.
Allergy
|
January 7, 2011
Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis
M Niedoszytko, J N G Oude Elberink, M Bruinenberg, et al.
The Journal of Allergy and Clinical Immunology
|
March 19, 2013
Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis
Bjorn van Anrooij, Eveline van der Veer, Jan G R de Monchy, et al.
Clinical Immunology (Orlando, Fla.)
|
December 27, 2011
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
J J Hofstra, I Kleine Budde, E van Twuyver, et al.
Allergy
|
March 23, 2012
Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions
J J van Doormaal, E van der Veer, P C van Voorst Vader, et al.
The European Respiratory Journal
|
February 13, 2010
Application of a prediction model for work-related sensitisation in bakery workers
E Meijer, E Suarthana, J Rooijackers, et al.
Page
of 5